Advertisement

Tumor Biology

, Volume 35, Issue 7, pp 7115–7123 | Cite as

The polymorphism interleukin-8 -251A/T is associated with a significantly increased risk of cancers from a meta-analysis

  • Ziliang Wang
  • Yang Liu
  • Lina Yang
  • Sheng Yin
  • Rongyu Zang
  • Gong Yang
Research Article

Abstract

Emerging evidences show that interleukin-8 (IL-8) has important regulatory functions in tumorigenesis. IL-8 -251A/T is a single nucleotide polymorphism in the promoter region of the IL-8 gene and affects IL-8 production. Analysis of previous studies on the association of -251A/T polymorphism with different cancer types remained to be illustrated. To further assess the effect of -251A/T polymorphism on cancer risks, we performed this meta-analysis, up to November 2013, of 12,917 cases with different cancer types and 17,689 controls from 47 published case-control designed studies. Statistical analyses were performed using STATA 11.0 software. Crude odds ratios (ORs) with 95 % confidence intervals (CIs) were used to assess the strength of associations. ORs with 95 % CIs for IL-8 -251A/T polymorphism and cancer were estimated using fixed- and random-effects models when appropriate. Significantly increased risks were found in overall under the models of A allele vs. T allele, AA vs. TT, and AA vs. AT/TT. Significantly elevated risks were observed in breast cancer under the models of A allele vs. T allele, AT vs. TT, AA/AT vs. TT, and AA vs. AT/TT, and in nasopharyngeal carcinoma under the models of AT vs. TT, AA/AT vs. TT, and AA vs. AT/TT. We found that significantly elevated risks were observed in the Asian population and hospital-based studies in all comparison models. Thus, this meta-analysis indicates that IL-8 -251A/T polymorphism is associated with a significantly increased risk of cancers and may provide evidence-based medical certificate to study the cancer susceptibility.

Keywords

IL-8 -251A/T polymorphism Cancer risk 

Notes

Acknowledgments

We thank Dr. Xiaofeng Wang for her critical comments of this manuscript.

Conflicts of interest

None

References

  1. 1.
    Shimizu Y, Kondo S, Shirai A, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer. Auris Nasus Larynx. 2008;35:381–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Xue H, Liu J, Lin B, et al. A meta-analysis of interleukin-8–251 promoter polymorphism associated with gastric cancer risk. PLoS One. 2012;7:e28083.PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Taguchi A, Ohmiya N, Shirai K, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev. 2005;14:2487–93.CrossRefPubMedGoogle Scholar
  4. 4.
    Ye BD, Kim SG, Park JH, et al. The interleukin-8–251 A allele is associated with increased risk of noncardia gastric adenocarcinoma in Helicobacter pylori-infected Koreans. J Clin Gastroenterol. 2009;43:233–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Liu CM, Yeh CJ, Yu CC, et al. Impact of interleukin-8 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan. Oral Dis. 2012;18:307–14.CrossRefPubMedGoogle Scholar
  6. 6.
    Kamangar F, Abnet CC, Hutchinson AA, et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control. 2006;17:117–25.CrossRefPubMedGoogle Scholar
  7. 7.
    Shirai K, Ohmiya N, Taguchi A, et al. Interleukin-8 gene polymorphism associated with susceptibility to non-cardia gastric carcinoma with microsatellite instability. J Gastroenterol Hepatol. 2006;21:1129–35.CrossRefPubMedGoogle Scholar
  8. 8.
    Lu W, Pan K, Zhang L, et al. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005;26:631–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Lee WP, Tai DI, Lan KH, et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res. 2005;11:6431–41.CrossRefPubMedGoogle Scholar
  10. 10.
    Savage SA, Hou L, Lissowska J, et al. Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev. 2006;15:589–91.CrossRefPubMedGoogle Scholar
  11. 11.
    Felipe AV, Silva TD, Pimenta CA, et al. Interleukin-8 gene polymorphism and susceptibility to gastric cancer in a Brazilian population. Biol Res. 2012;45:369–74.CrossRefPubMedGoogle Scholar
  12. 12.
    Vinagre RM, Corvelo TC, Arnaud VC, et al. Determination of strains of Helicobacter pylori and of polymorphism in the interleukin-8 gene in patients with stomach cancer. Arq Gastroenterol. 2011;48:46–51.CrossRefPubMedGoogle Scholar
  13. 13.
    Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, et al. Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8–251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer. 2007;7:70.PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Canedo P, Castanheira-Vale AJ, Lunet N, et al. The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. Eur J Cancer Prev. 2008;17:28–32.CrossRefPubMedGoogle Scholar
  15. 15.
    Ohyauchi M, Imatani A, Yonechi M, et al. The polymorphism interleukin 8–251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut. 2005;54:330–5.PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Kang JM, Kim N, Lee DH, et al. The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea. J Clin Gastroenterol. 2009;43:420–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Kamali-Sarvestani E, Bazargani A, Masoudian M, et al. Association of H. pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol. 2006;12:5205–10.PubMedCentralPubMedGoogle Scholar
  18. 18.
    Crusius JB, Canzian F, Capellá G, et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol. 2008;19:1894–902.CrossRefPubMedGoogle Scholar
  19. 19.
    Ko KP, Park SK, Cho LY, et al. Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk. J Nutr. 2009;139:1008–12.CrossRefPubMedGoogle Scholar
  20. 20.
    Zhang L, Du C, Guo X, et al. Interleukin-8-251A/T polymorphism and Helicobacter pylori infection risk for the development of gastric cardiac adenocarcinoma in a high-incidence area of China. Mol Biol Rep. 2010;37:3983–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Bo S, Dianliang Z, Hongmei Z, et al. Association of interleukin-8 gene polymorphism with cachexia from patients with gastric cancer. J Interferon Cytokine Res. 2010;30:9–14.CrossRefPubMedGoogle Scholar
  22. 22.
    Savage SA, Abnet CC, Mark SD, et al. Variants of the IL8 and IL8RB genes and risk for gastric for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2004;13:2251–7.PubMedGoogle Scholar
  23. 23.
    Rafrafi A, Chahed B, Kaabachi S, et al. Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: a case control study. Hum Immunol. 2013;74:1368–74.CrossRefPubMedGoogle Scholar
  24. 24.
    Campa D, Hung RJ, Mates D, et al. Lack of association between -251 T>A polymorphism of IL8 and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2005;14:2457–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Campa D, Zienolddiny S, Maggini V, et al. Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis. 2004;25:229–35.CrossRefPubMedGoogle Scholar
  26. 26.
    Vogel U, Christensen J, Wallin H, et al. Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat Res. 2008;639:89–100.CrossRefPubMedGoogle Scholar
  27. 27.
    Theodoropoulos G, Papaconstantinou I, Felekouras E, et al. Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol. 2006;12:5037–43.PubMedCentralPubMedGoogle Scholar
  28. 28.
    Cacev T, Radosević S, Krizanac S, et al. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis. 2008;29:1572–80.CrossRefPubMedGoogle Scholar
  29. 29.
    Landi S, Moreno V, Gioia-Patricola L, et al. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res. 2003;63:3560–6.PubMedGoogle Scholar
  30. 30.
    Vogel U, Christensen J, Dybdahl M, et al. Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutat Res. 2007;624:88–100.CrossRefPubMedGoogle Scholar
  31. 31.
    Wilkening S, Tavelin B, Canzian F, et al. Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis. 2008;29:1202–6.CrossRefPubMedGoogle Scholar
  32. 32.
    Gunter MJ, Canzian F, Landi S, et al. Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2006;15:1126–31.CrossRefPubMedGoogle Scholar
  33. 33.
    Smith KC, Bateman AC, Fussell HM, et al. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet. 2004;31:167–73.CrossRefPubMedGoogle Scholar
  34. 34.
    Snoussi K, Mahfoudh W, Bouaouina N, et al. Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. Hum Immunol. 2006;67:13–21.CrossRefPubMedGoogle Scholar
  35. 35.
    Kamali-Sarvestani E, Aliparasti MR, Atefi S. Association of interleukin-8 (IL-8 or CXCL8) -251 T/A and CXCR2 + 1208C/T gene polymorphisms with breast cancer. Neoplasma. 2007;54:484–9.PubMedGoogle Scholar
  36. 36.
    Snoussi K, Mahfoudh W, Bouaouina N, et al. Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility aggressiveness. BMC Cancer. 2010;10:283.PubMedCentralCrossRefPubMedGoogle Scholar
  37. 37.
    Vogel U, Christensen J, Nexø BA, et al. Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. Carcinogenesis. 2007;28:427–34.CrossRefPubMedGoogle Scholar
  38. 38.
    McCarron SL, Edwards S, Evans PR, et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res. 2002;62:3369–72.PubMedGoogle Scholar
  39. 39.
    Yang HP, Woodson K, Taylor PR, et al. Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial. Eur J Cancer Prev. 2006;15:249–53.CrossRefPubMedGoogle Scholar
  40. 40.
    Michaud DS, Daugherty SE, Berndt SI, et al. Genetic polymorphisms of interleukin-1B(IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res. 2006;66:4525–30.CrossRefPubMedGoogle Scholar
  41. 41.
    Wang MH, Helzlsouer KJ, Smith MW, et al. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate. 2009;69:874–85.PubMedCentralCrossRefPubMedGoogle Scholar
  42. 42.
    Ben Nasr H, Chahed K, Mestiri S, et al. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma. Hum Immunol. 2007;68:761–9.CrossRefPubMedGoogle Scholar
  43. 43.
    Wei YS, Lan Y, Tang RG, et al. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clin Immunol. 2007;125:309–17.CrossRefPubMedGoogle Scholar
  44. 44.
    Tai SH, Wei YS, Wang P, et al. Genetic polymorphisms of interferon-C and interleukin-8 in patients with nasopharyngeal carcinoma. J Sichuan Univ (Med Sci Edi). 2007;38:862–5.Google Scholar
  45. 45.
    Campa D, Hashibe M, Zaridze D, et al. Association of common polymorphisms in inflammatory genes with risk of developing cancers of the upper aerodigestive tract. Cancer Causes Control. 2007;18:449–55.CrossRefPubMedGoogle Scholar
  46. 46.
    Kietthubthew S, Wickliffe J, Sriplung H, et al. Association of polymorphisms in proinflammatory cytokine genes with the development of oral cancer in Southern Thailand. Int J Hyg Environ Health. 2010;213:146–52.CrossRefPubMedGoogle Scholar
  47. 47.
    Hu YP, Liu B, Su T, et al. IL-8-251single nucleotide polymorphism in the recurrence of squamous cell carcinoma of tongue. J Pract Stomatol. 2012;28:328–32.Google Scholar
  48. 48.
    Gao LB, Pan XM, Jia J, et al. IL-8–251A/T polymorphism is associated with decreased cancer risk among population-based studies: evidence from a meta-analysis. Eur J Cancer. 2010;46(8):1333–43.CrossRefPubMedGoogle Scholar
  49. 49.
    Wang N, Zhou R, Wang C, et al. -251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case-control studies. Mol Biol Rep. 2012;39(3):2831–41.CrossRefPubMedGoogle Scholar
  50. 50.
    Ke J, Zhong R, Zhang T, et al. Replication study in Chinese population and meta-analysis supports association of the 5p15.33 locus with lung cancer. PLoS One. 2013;8:e62485.PubMedCentralCrossRefPubMedGoogle Scholar
  51. 51.
    Cheng D, Hao Y, Zhou W, et al. Positive association between Interleukin-8–251A > T polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis. Cancer Cell Int. 2013;13:100.PubMedCentralCrossRefPubMedGoogle Scholar
  52. 52.
    Wang Z, Wang C, Zhao Z, et al. Association between -251A > T polymorphism in the interleukin-8 gene and oral cancer risk: a meta-analysis. Gene. 2013;522:168–76.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  1. 1.Cancer InstituteFudan University Shanghai Cancer CenterShanghaiChina
  2. 2.Department of Gynecological OncologyFudan University Shanghai Cancer CenterShanghaiChina
  3. 3.Department of Oncology, Shanghai Medical CollegeFudan UniversityShanghaiChina
  4. 4.Central Laboratory, the Fifth People’s Hospital of ShanghaiFudan UniversityShanghaiChina

Personalised recommendations